AB2026-05-006 Medical policies
Summary
Capital Blue Cross is implementing major changes to medical specialty injectable policies and multiple medical policies. A new drug Exdensur will require prior authorization, over 30 injectable medications will have revised policies, and new prior authorization requirements are being added for bio-engineered skin substitutes and other procedures.
Get alerts when payers change rules like this one
We check Capital Blue Cross and other payers every day and email you when a change matches your specialty and state.